Google AI
The Times Australia

Times Media

Clinical Trial Industry Veteran Paul Malan Joins Bioforum as Vice President of Biostatistics

NESS ZIONA, Israel, April 21, 2021 /PRNewswire/ -- Bioforum[1], a data-focused contract research organization (CRO) serving life sciences organizations worldwide, today announced that Paul Malan has joined the company as Vice President of Biostatistics. In this new role, Malan will drive the global expansion of Bioforum's biostatistics capabilities as well as the company's functional service provider (FSP)[2] division, designed to provide flexible, scalable partnership support to clinical trial sponsors of all sizes, with a key focus on small-to-midsize life sciences organizations and innovative startups.

Malan, who brings more than 17 years of experience to Bioforum, will lead a global team responsible for the statistical aspects of planning and executing clinical trials, including study design, statistical analysis and reporting. He joins Bioforum from IQVIA, where he began his career as a statistician in 2003. Over the years, Malan held roles of increasing responsibility at IQVIA, moving up the ranks to serve as Country Manager for the IQVIA Biostatistics and Statistical Programmer groups in South Africa. In addition, Malan led a major FSP program for IQVIA, overseeing the work of more than 235 biostatisticians and statistical programmers dedicated to a large, multinational pharmaceutical company. 

"Paul's guidance will help ensure our success designing and executing innovative strategies for our clients' novel clinical trials, as we continue to expand in the US, Europe, Asia Pacific, South Africa and Israel," said Amir Malka, Bioforum's Co-Founder and President. "We feel fortunate to have Paul on board, working closely with sponsors, regulators and other stakeholders across the global ecosystem to maximize the success of vital research studies that have the potential to bring needed new therapies to patients." 

A member of the South African Statistical Association, Malan holds a master's degree in statistics from the University of the Free State in Bloemfontein, South Africa. He has extensive experience in phase I – IV clinical trials, mapping and implementing data standards established by the Clinical Data Interchange Standards Consortium (CDISC), and Good Clinical Practice (GCP) guidelines.

"It's a thrill to join Bioforum at this exciting growth stage and have the opportunity to contribute to enriching the company's unique value proposition," Malan added. "I'm honored to be working alongside such a skilled and passionate team as we build a world-class biometrics and data analytics organization that will leverage statistical knowledge and technology to provide quality expertise and services to our clients and partners around the world."

About Bioforum the Data Masters

Bioforum is a data-focused contract research organization (CRO), serving clients worldwide in optimizing the collection, standardization, and reporting of clinical research data. We strive to consistently improve and innovate data processes, enabling the most efficient data submissions for our clients across the life sciences industry worldwide. From our offices in Israel, the U.S., Australia, and South Africa, our multidisciplinary team provides in-depth expertise and delivers high-quality solutions, including medical writing, data management, statistical programming and biostatistics. To learn more about us and our services, visit bioforumgroup.com or find us on LinkedIn at linkedin.com/company/bioforum-ltd.[3][4][5][6][7][8]

Bioforum ContactTali Rahinsteintalir@bioforumgroup.com[9]

 

References

  1. ^ Bioforum (bioforumgroup.com)
  2. ^ functional service provider (FSP) (bioforumgroup.com)
  3. ^ medical writing (bioforumgroup.com)
  4. ^ data management (bioforumgroup.com)
  5. ^ statistical programming (bioforumgroup.com)
  6. ^ biostatistics (bioforumgroup.com)
  7. ^ bioforumgroup.com (bioforumgroup.com)
  8. ^ linkedin.com/company/bioforum-ltd. (www.linkedin.com)
  9. ^ talir@bioforumgroup.com (www.prnasia.com)

Read more https://www.prnasia.com/story/archive/3349361_AE49361_0

Business Times

Why the Evening Edition Is Returning

There was a time when Australians bought two newspapers a day. The morning paper delivered the overnight news. The evening...

Public Tenders: The Business Opportunity Many Australian SMEs Ove…

Winning new customers is one of the biggest challenges facing any business. While many companies compete for private sector...

What Employers Look for Beyond the Résumé

A résumé tells an employer where you have studied, where you have worked and what qualifications you hold. What it cannot ...

Technology

SpaceX changed spaceflight. Now Chi…

When SpaceX first landed a Falcon 9 booster vertically on a floating drone ship, many experts desc...

Local News

Fremantle Ports to trial project to…

Fremantle Ports has partnered with Byssal and DevelopmentWA to trial an innovative nature-based pilo...

Culture

SpaceX changed spaceflight. Now China is prov…

When SpaceX first landed a Falcon 9 booster vertically on a floating drone ship, many experts desc...

Travel

Why Vietnam's Ancient Cave Region Is Bec…

For years, Phong Nha in central Vietnam has attracted adventurous travellers drawn by its spectacu...

The Times Features

Public Tenders: The Business Opportunity Many Australia…

Winning new customers is one of the biggest challenges facing any business. While many companies c...

Dementia Cases Rise as Australia Ages: Is the Nation Re…

Australia's ageing population is bringing dementia into sharper focus, with health experts and gov...

Why Vietnam's Ancient Cave Region Is Becoming Asia…

For years, Phong Nha in central Vietnam has attracted adventurous travellers drawn by its spectacu...